Kairos Pharma Ltd

CUSIP 48301N104COMKAPAQ4 2025

Kairos Pharma Ltd — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest Aug 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Aug 14, 2025	Armistice Capital, LLC	13G/A	5.0%	884.9K	SEC
2	May 15, 2025	Armistice Capital, LLC	13G	10.0%	1.70M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Citadel Advisors LLC	321.7K	$228.4K
2	Vanguard Group Inc	131.8K	$93.6K
3	Two Sigma Investments, LP	94.0K	$66.7K
4	Geode Capital Management, LLC	72.8K	$51.7K
5	Xtx Topco Ltd	48.5K	$34.4K
6	Sevenbridge Financial Group, LLC	44.3K	$31.9K
7	Aptus Capital Advisors, LLC	44.3K	$31.4K
8	State Street Corp	24.1K	$17.1K
9